
JAMA Psychiatry Author Interviews
Interviews with authors of articles from JAMA Psychiatry. JAMA Psychiatry is an international peer-reviewed journal for clinicians, scholars, and research scientists in psychiatry, mental health, behavioral science, and allied fields. JAMA Psychiatry strives to publish original, state-of-the-art studies and commentaries of general interest to clinicians, scholars, and research scientists in the field. The journal seeks to inform and to educate its readers as well as to stimulate debate and further exploration into the nature, causes, treatment, and public health importance of mental illness.
Latest episodes

Jul 9, 2025 • 16min
Incidence and Nature of Antidepressant Discontinuation Symptoms
Interview with Sameer Jauhar, PhD, author of Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD. Related Content: Incidence and Nature of Antidepressant Discontinuation Symptoms

Jun 25, 2025 • 23min
Polygenic Risk, Psychopathology, and Personalized Functional Brain Network Topography in Adolescence
Interview with Aaron Alexander-Bloch, MD, PhD, and Kevin Y. Sun, BA, authors of Polygenic Risk, Psychopathology, and Personalized Functional Brain Network Topography in Adolescence. Hosted by John Torous, MD. Related Content: Polygenic Risk, Psychopathology, and Personalized Functional Brain Network Topography in Adolescence

Apr 16, 2025 • 20min
Cognitive Behavior Therapy for Mental Disorders in Adults
Pim Cuijpers, PhD, is a leading figure in clinical psychology, and in this engaging conversation, he dives deep into the world of Cognitive Behavioral Therapy (CBT). He discusses its efficacy in treating conditions like anxiety and depression, supported by a meta-analysis of 375 studies. Cuijpers highlights the advantages of group therapy versus individual formats and stresses the importance of robust control conditions in research. He also explores future innovations in mental health therapy, advocating for accessible, evidence-based treatment globally.

Mar 26, 2025 • 20min
Effective Components of Collaborative Care for Depression in Primary Care
Interview with Professor Jurgen Unutzer, MD, author of Effective Components of Collaborative Care for Depression in Primary Care: An Individual Participant Data Meta-Analysis. Hosted by John Torous, MD. Related Content: Effective Components of Collaborative Care for Depression in Primary Care

Feb 26, 2025 • 27min
Providing Timely Access to Diverse Youth Mental Health Services
Interview with Srividya N. Iyer, PhD, author of An Approach to Providing Timely Mental Health Services to Diverse Youth Populations. Hosted by John Torous, MD. Related Content: An Approach to Providing Timely Mental Health Services to Diverse Youth Populations

Jan 29, 2025 • 15min
Specialty Crisis Services Before and After the 988 Suicide and Crisis Lifeline Launch
Interview with Jonathan Cantor, PhD, author of Changes in Specialty Crisis Services Offered Before and After the Launch of the 988 Suicide and Crisis Lifeline. Hosted by John Torous, MD. Related Content: Changes in Specialty Crisis Services Offered Before and After the Launch of the 988 Suicide and Crisis Lifeline

Dec 23, 2024 • 21min
Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning
Interview with Jayani Jayawardhana, PhD, author of Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning. Hosted by John Torous, MD, MBI. Related Content: Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning

Nov 13, 2024 • 19min
ED Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder
Interview with Daniel T. Myran, MD, MPH, author of Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder. Hosted by John Torous, MD. Related Content: Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder

18 snips
Oct 30, 2024 • 22min
Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment
Benoit H. Mulsant, MD, MS, and Tarek K. Rajji, MD, both from the Toronto Dementia Research Alliance, dive into groundbreaking research on cognitive decline linked to major depressive disorder and mild cognitive impairment. They discuss innovative treatments, like transcranial direct current stimulation, and the significance of combining cognitive remediation with emerging therapies. Key findings reveal how these interventions promote neuroplasticity and enhance cognitive function. The conversation also touches on the role of genetics in Alzheimer’s and the pressing need for preventive strategies in vulnerable populations.

Sep 4, 2024 • 19min
Adverse Events in Studies of Classic Psychedelics
David B. Yaden, a psychedelic researcher, and Jared T. Hinkle, a medical doctor specializing in psychedelic studies, dive into the intricate world of classic psychedelics. They discuss a recent systematic review highlighting adverse events linked to substances like psilocybin and LSD. The conversation emphasizes the need for balanced evaluations of risks and benefits, improving reporting standards, and the necessity for long-term monitoring in clinical studies. Tune in for insights on psychedelics' therapeutic potential and the ongoing challenges in their research!